Toll-like Receptor Activation Suppresses ER Stress Factor CHOP and Translation Inhibition Through Activation of EIF2B
Overview
Affiliations
Activation of Toll-like receptors (TLRs) induces the endoplasmic reticulum (ER) unfolded protein response (UPR) to accommodate essential protein translation. However, despite increased levels of phosphorylated eIF2α (p-eIF2α), a TLR-TRIF-dependent pathway assures that the cells avoid CHOP induction, apoptosis and translational suppression of critical proteins. As p-eIF2α decreases the functional interaction of eIF2 with eIF2B, a guanine nucleotide exchange factor (GEF), we explored the hypothesis that TLR-TRIF signalling activates eIF2B GEF activity to counteract the effects of p-eIF2α. We now show that TLR-TRIF signalling activates eIF2B GEF through PP2A-mediated serine dephosphorylation of the eIF2B ɛ-subunit. PP2A itself is activated by decreased Src-family-kinase-induced tyrosine phosphorylation of its catalytic subunit. Each of these processes is required for TLR-TRIF-mediated CHOP suppression in ER-stressed cells in vitro and in vivo. Thus, in the setting of prolonged, physiologic ER stress, a unique TLR-TRIF-dependent translational control pathway enables cells to carry out essential protein synthesis and avoid CHOP-induced apoptosis while still benefiting from the protective arms of the UPR.
Salvador-Mira M, Sanchez-Cordoba E, Solivella M, Nombela I, Puente-Marin S, Chico V Front Immunol. 2024; 15:1466870.
PMID: 39660123 PMC: 11628393. DOI: 10.3389/fimmu.2024.1466870.
TRIF-dependent signaling and its role in liver diseases.
Hu L, Cheng Z, Chu H, Wang W, Jin Y, Yang L Front Cell Dev Biol. 2024; 12:1370042.
PMID: 38694821 PMC: 11061444. DOI: 10.3389/fcell.2024.1370042.
Control of Selective mRNA Translation in Neuronal Subcellular Compartments in Health and Disease.
Cagnetta R, Flanagan J, Sonenberg N J Neurosci. 2023; 43(44):7247-7263.
PMID: 37914402 PMC: 10621772. DOI: 10.1523/JNEUROSCI.2240-22.2023.
Toll-like receptors 2 and 4 stress signaling and sodium-glucose cotransporter-2 in kidney disease.
Shelke V, Kale A, Anders H, Gaikwad A Mol Cell Biochem. 2022; 478(9):1987-1998.
PMID: 36586092 DOI: 10.1007/s11010-022-04652-5.
Munier J, Marty V, Spigelman I Alcohol Clin Exp Res. 2022; 46(8):1384-1396.
PMID: 35791038 PMC: 9612407. DOI: 10.1111/acer.14900.